Clinical Trials Directory

Trials / Completed

CompletedNCT01277822

Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)

The 8 Weeks, Multicenter, Randomized, Double-blind, Clinical Study To Evaluate Efficacy Of Treatment With Losartan/Amlodipine 100/5 mg Combination Compared To Amlodipine 10 mg Monotherapy In Hypertensive Patients Who Are Not Appropriately Respond To Amlodipine 5 mg Monotherapy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
334 (actual)
Sponsor
Organon and Co · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study will determine whether using losartan and amlodipine together will be non-inferior in lowering blood pressure than amlodipine alone.

Conditions

Interventions

TypeNameDescription
DRUGLosartan (+) amlodipineOne tablet containing 100 mg losartan potassium and 5 mg amlodipine camsylate, orally, once daily, for 8 weeks.
DRUGPlacebo to match losartan/amlodipine tabletsOne tablet containing placebo, orally, once daily, for 8 weeks.
DRUGAmlodipine camsylate2 tablets each containing 5 mg amlodipine, orally, once daily, for 8 weeks.
DRUGPlacebo to match amlodipine2 tablets containing placebo, orally, once daily, for 8 weeks.

Timeline

Start date
2011-05-30
Primary completion
2013-04-22
Completion
2013-04-22
First posted
2011-01-17
Last updated
2024-06-20
Results posted
2014-04-24

Source: ClinicalTrials.gov record NCT01277822. Inclusion in this directory is not an endorsement.